Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1991-12-31
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-3050
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
849
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:1955916-Aminocaproic Acids,
pubmed-meshheading:1955916-Anticonvulsants,
pubmed-meshheading:1955916-Dose-Response Relationship, Drug,
pubmed-meshheading:1955916-Electroencephalography,
pubmed-meshheading:1955916-Epilepsy,
pubmed-meshheading:1955916-Humans,
pubmed-meshheading:1955916-Vigabatrin
|
pubmed:year |
1991
|
pubmed:articleTitle |
Evaluation of vigabatrin in refractory epilepsy.
|
pubmed:publicationType |
Letter,
Comment
|